Solasulfone

Solasulfone
Names
	IUPAC name Tetrasodium 3,3'-[sulfonylbis(benzene-4,1-diylimino)]bis(1-phenylpropane-1,3-disulfonate)
	Other names Solapsone; Sulfetrone
Identifiers
CAS Number	133-65-3;
3D model (JSmol)	Interactive image;
ChemSpider	8305;
ECHA InfoCard	100.004.652
PubChem CID	8626;
UNII	H12JE4313S ;
CompTox Dashboard (EPA)	DTXSID50927894 ;
	InChI InChI=1S/C30H32N2O14S5.4Na/c33-47(34,25-15-11-23(12-16-25)31-29(50(41,42)43)19-27(48(35,36)37)21-7-3-1-4-8-21)26-17-13-24(14-18-26)32-30(51(44,45)46)20-28(49(38,39)40)22-9-5-2-6-10-22;;;;/h1-18,27-32H,19-20H2,(H,35,36,37)(H,38,39,40)(H,41,42,43)(H,44,45,46);;;;/q;4*+1/p-4;
	SMILES [Na+].[Na+].[Na+].[Na+].[O-]S(=O)(=O)C(c1ccccc1)CC(Nc2ccc(cc2)S(=O)(=O)c4ccc(NC(S([O-])(=O)=O)CC(c3ccccc3)S([O-])(=O)=O)cc4)S([O-])(=O)=O;
Properties
Chemical formula	C30H28N2Na4O14S5
Molar mass	892.81 g·mol−1
	Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). Infobox references

Solasulfone is an antileprotic drug developed from the parent compound sulphetrone.^[1] It was first described and evaluated in the 1930s and 1940s as an antibacterial agent for the treatment of tuberculosis and various other infections, and later found to be effective in the treatment of leprosy.^[2]

References

^ Chemistry for Pharmacy and the Life Sciences (1996, Pearson Education Limited) Thomas, Gareth; ppg. 349-350
^ Brownlee, George; Green, A. F.; Woodbine, M. (March 1948). "Sulphetrone*: A Chemotherapeutic Agent for Tuberculosis: Pharmacology and Chemotherapy". British Journal of Pharmacology and Chemotherapy. 3 (1): 15–28. doi:10.1111/j.1476-5381.1948.tb00348.x. PMC 1509804. PMID 18904720.

This systemic antibiotic-related article is a stub. You can help Wikipedia by expanding it.

[1] Chemistry for Pharmacy and the Life Sciences (1996, Pearson Education Limited) Thomas, Gareth; ppg. 349-350

[2] Brownlee, George; Green, A. F.; Woodbine, M. (March 1948). "Sulphetrone*: A Chemotherapeutic Agent for Tuberculosis: Pharmacology and Chemotherapy". British Journal of Pharmacology and Chemotherapy. 3 (1): 15–28. doi:10.1111/j.1476-5381.1948.tb00348.x. PMC 1509804. PMID 18904720.

[1]

[2]